Your browser doesn't support javascript.
loading
Correlates of protection for booster doses of the SARS-CoV-2 vaccine BNT162b2.
Hertz, Tomer; Levy, Shlomia; Ostrovsky, Daniel; Oppenheimer, Hanna; Zismanov, Shosh; Kuzmina, Alona; Friedman, Lilach M; Trifkovic, Sanja; Brice, David; Chun-Yang, Lin; Cohen-Lavi, Liel; Shemer-Avni, Yonat; Cohen-Lahav, Merav; Amichay, Doron; Keren-Naus, Ayelet; Voloshin, Olga; Weber, Gabriel; Najjar-Debbiny, Ronza; Chazan, Bibiana; McGargill, Maureen A; Webby, Richard; Chowers, Michal; Novack, Lena; Novack, Victor; Taube, Ran; Nesher, Lior; Weinstein, Orly.
Afiliación
  • Hertz T; Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. thertz@post.bgu.ac.il.
  • Levy S; National Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel. thertz@post.bgu.ac.il.
  • Ostrovsky D; Vaccine and Infectious Disease Division, Fred Hutch Cancer Research Center, Seattle, USA. thertz@post.bgu.ac.il.
  • Oppenheimer H; Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Zismanov S; National Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Kuzmina A; Clinical Research Center, Soroka University Medical Center, and the faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Friedman LM; Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Trifkovic S; National Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Brice D; Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Chun-Yang L; National Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Cohen-Lavi L; Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Shemer-Avni Y; Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Cohen-Lahav M; National Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Amichay D; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Keren-Naus A; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Voloshin O; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Weber G; Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Najjar-Debbiny R; National Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Chazan B; Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • McGargill MA; Laboratory of Virology, Soroka University Medical Center, Beer-Sheva, Israel.
  • Webby R; Laboratory of Management, Soroka University Medical Center, Beer-Sheva, Israel.
  • Chowers M; Central Laboratory, Clalit Health Services & Dept. of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheba, Israel.
  • Novack L; Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Novack V; Laboratory of Virology, Soroka University Medical Center, Beer-Sheva, Israel.
  • Taube R; Laboratory of Virology, Soroka University Medical Center, Beer-Sheva, Israel.
  • Nesher L; Infectious Diseases Unit, Lady Davis Carmel Medical Center, Haifa, Israel.
  • Weinstein O; Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Nat Commun ; 14(1): 4575, 2023 07 29.
Article en En | MEDLINE | ID: mdl-37516771
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article País de afiliación: Israel
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article País de afiliación: Israel